Clinical Research Directory

Inclusion Criteria: 1. With either gender aged between 18 to 40 (inclusive) years old. 2. Diagnosis of myopia in both eyes, each ranging from -0.50D to 6.00D with manifest astigmatism of ≤ 1.00D per eye. 3. Understands and signs an informed consent form (ICF). 4. Willing to adhere to the instructions set forth in this study as well as understand and complete all specified evaluation. 5. Willing and able to refrain from using any other contact lenses other than those provided for the duration of the study. 6. Has experience and capability of wearing soft contact lenses. 7. Be a habitual soft contact lenses wearer in both eyes, defined as wearing lenses for at least 8 hours per day, 5 days per week, for a minimum duration of 30 days. 8. Tear breakup time (TBUT) \> 5 seconds in each eye. Exclusion Criteria: 1. Eyes with abnormality or disease as follows: 1. Evidence of lid abnormality or infection (e.g., entropion, ectropion, chalazia, and recurrent styes). 2. Clinically significant slit lamp findings (e.g., infiltrates or other slit lamp findings Level 2 or above: corneal edema, tarsal abnormalities, and conjunctival injection). 3. Other active ocular disease (e.g., uveitis, corneal epithelial defect, severe dry eye, lacrimal duct defect, glaucoma, cornea \[infiltrates\], conjunctiva, lids, and intraocular infection or inflammation of an allergic, bacterial, or viral etiology). 4. History of recurrent corneal erosions. 5. Aphakia. 2. Ocular or systemic allergies or diseases that may interfere with contact lens wear, occur within 2 weeks prior to the Screening Visit. 3. Use of topical ocular medications, except artificial tear, within 7 days prior to the Screening Visit. 4. History of refractive, ocular, or intraocular surgery. 5. Participation in any clinical trial (with the exception of retrospectives studies) within 30 days prior to the Screening Visit. 6. Have risks in dangerous and significant eye edema, congestions, corneal abrasion or neovascularization when wearing contact lens. 7. Any corneal surface roughness. 8. Unable to achieve best corrected visual acuity (BCVA) of logMAR 0.1 or better in each eye at distance using manifest refraction. 9. Females who are pregnant, breastfeeding or who intend to become pregnant over the course of the study. 10. Current drug or alcohol use or dependence that, in the opinion of the Investigator, would interfere with adherence to study requirement. 11. Allergy to any component in the study product. 12. Subjects who wore monovision, multifocal, toric, or rigid contact lenses within 30 days prior to the Screening Visit. Note: Monovision is defined as a vision correction method for treating presbyopia in which the dominant eye is corrected for distance vision and the non-dominant eye is corrected for near vision. 13. Use of systemic medications (e.g., chronic steroid use) that are known to interfere with contact lenses wear at the Investigators discretion within 14 days prior to the Screening Visit. 14. Other conditions not suitable for participating in this study judged by the Investigators. 15. Live in dusty or pharmaceutical environments.